ArticleEndocrine2025
PLIN5 regulates lipid metabolism via PGC-1α/Drp1 signaling in islet β-cells.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Carnosine and Acyl Carnitines as Metabolic Determinants of Muscle Phenotypic Differences Between Longissimus Dorsi and Triceps Brachii in Hanzhong Sheep.Foods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimsThis study investigated the protective role of Perilipin 5 (PLIN5) in pancreatic β-cell dysfunction under diabetic conditions, focusing on its regulatory effects on lipid metabolism and mitochondrial dynamics. MATERIALS AND
methodsDiabetic db/db mice and pancreatic beta cell line INS-1 were employed to investigate the role of PLIN5 in insulin secretion and lipid metabolism under high glucose (HG) conditions. The phenotypic changes were evaluated by staining and measurement of biochemical indexes. The molecular mechanism was explored by biological techniques such as Western blotting, qPCR, immunofluorescence and lentivirus infection.
resultsPLIN5 was decreased under diabetic conditions which was related to lipid accumulation in the pancreas. The in vitro knockdown of PLIN5 promoted apoptosis in INS-1 cells, leading to a reduction in insulin secretion mediated by lipid accumulation. PLIN5 knockdown also promoted mitochondrial dysfunction in normal-glucose-cultured INS-1 cells mainly through decreasing PGC-1α and increasing Drp1 levels. In contrast, PLIN5 overexpression reversed the damage caused by HG in INS-1 cells, such as increased apoptosis and lipid accumulation, mitochondrial dysfunction and weakened capacity of insulin secretion. PLIN5 overexpression also blunted the inhibitory effects of HG on PGC-1α and Drp1 expressions. The reduced expression of PLIN5 also led to decreased binding of PGC-1α to the promoter region of Drp1.
conclusionsOur data indicate that PLIN5 acts as a potent regulator of lipid accumulation in pancreatic β cells treated with HG through the modulation of PGC-1α and Drp1.
Indexed as
Identifiers
40884681What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.